培训资料--社区脑卒中一级预防培训讲学.pptVIP

上海科学院上海市脑血管病防治研究所;预防形势;;AHA卒中一级预防指南;内容提要;Well-documented and modifiable risk factors ;Less well-documented and potentially modifiable risk factors ;糖尿病;高同型半胱氨酸血症 ;偏头痛 ;高尿酸血症;内容提要;阿司匹林与卒中一级预防;阿司匹林与卒中一级预防;阿司匹林用于卒中一级预防荟萃分析;阿司匹林一级预防试验中各种血管事件概况;阿司匹林预防作用的相对值和绝对值;阿司匹林一级预防的亚组分析-性别;内容提要;无症状颈动脉狭窄与脑卒中风险;无症状颈动脉狭窄;无症状颈动脉狭窄;内容提要;Statins for the primary prevention of cardiovascular disease（2013）; All-cause mortality was reduced by statins (OR 0.86, 95% CI 0.79 to 0.94); as was combined fatal and non-fatal CVD RR 0.75 (95% CI 0.70 to 0.81), combined fatal and non-fatal CHD events RR 0.73 (95% CI 0.67 to 0.80) and combined fatal and non-fatal stroke (RR 0.78, 95% CI 0.68 to 0.89). Reduction of revascularisation rates (RR 0.62, 95% CI 0.54 to 0.72) was also seen. 他汀类药物应用于心血管病一级预防，总死亡、心脑血管总事件、冠状动脉事件、卒中事件以及血管重建率均显著降低。;Total cholesterol and LDL cholesterol were reduced in all trials but there was evidence of heterogeneity of effects. There was no evidence of any serious harm caused by statin prescription. Evidence available to date showed that primary prevention with statin is likely to be cost-effective and may improve patient quality of life. 欧美心血管疾病的发病率和死亡率显著降低，与他汀类药物的消耗显著相关。;中成药预防中风系统评价;内容提要;上海市申康医院发展中心慢性病综合预防项目;研究目标;主要研究内容;筛查手段;定量评估中风危险度;Framingham脑卒中风险积分规则;*;*;国人缺血性心血管病简易风险积分规则（女）;*;干预措施;小结：;*